{"id":298576,"date":"2019-10-16T23:00:17","date_gmt":"2019-10-17T06:00:17","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/10\/dmed-biopharma-a-china-us-eu-clinica\/"},"modified":"2019-10-16T23:13:55","modified_gmt":"2019-10-17T06:13:55","slug":"%e4%b8%ad%e7%be%8e%e7%b7%a0%e8%84%88%e7%b1%8c%e8%b3%875000%e8%90%ac","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/10\/%e4%b8%ad%e7%be%8e%e7%b7%a0%e8%84%88%e7%b1%8c%e8%b3%875000%e8%90%ac\/","title":{"rendered":"\u4e2d\u7f8e\u7de0\u8108\u7c4c\u8cc7$5000\u842c"},"content":{"rendered":"<p>\u7de0\u8108\u662f\u4e00\u5bb6\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u6b50\u76df\u63d0\u4f9b\u81e8\u5e8a\u8a66\u9a57\u670d\u52d9\u7684CRO(\u91ab\u85e5\u7814\u767c\u5408\u540c\u5916\u5305\u670d\u52d9\u6a5f\u69cb)\uff0c\u8a72\u516c\u53f8\u5b8c\u6210\u4e86\u8fd1$5000\u842c\u7684B\u8f2a\u878d\u8cc7\uff0c\u8a72\u8f2a\u878d\u8cc7\u7531\u7dad\u68a7\u8cc7\u672c\u9818\u6295\u3001\u541b\u806f\u8cc7\u672c\u3001\u555f\u660e\u5275\u6295\u3001\u79ae\u4f86\u4e9e\u6d32\u57fa\u91d1\u53c3\u6295\u3002\u7de0\u8108\u6210\u7acb\u65bc\u4e09\u5e74\u524d\uff0c\u81ea\u8a8d\u70ba\u662f\u201c\u4e0b\u4e00\u4ee3\u201d\u81e8\u5e8aCRO\uff0c\u5177\u6709\u9ad8\u6548\u7684\u904b\u71df\u3001IT\u670d\u52d9\u548c\u8de8\u5883\u5168\u7403\u8a66\u9a57\u65b9\u9762\u7684\u5c08\u696d\u77e5\u8b58\u3002 \u7de0\u8108\u6709600\u540d\u54e1\u5de5\u3002 \u6700\u8fd1\uff0c\u7de0\u8108\u6536\u8cfc\u4e86\u4f4d\u65bc\u7d10\u7d04\u7684\u5168\u65b9\u4f4d\u670d\u52d9CRO\u2014\u2014Target Health\uff0c\u4ee5\u64f4\u5c55\u5176\u5168\u7403\u696d\u52d9\u4e26\u6dfb\u52a0\u65b0\u6280\u8853\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>dMed Biopharma, a Shanghai CRO that offers clinical trial services in China, the US and the EU, completed a Series B financing of nearly $50 million, led by Vivo Capital and joined by Legend Capital, Qiming Venture Partners and Lilly Asia Ventures. Launched three years ago, dMed considers itself a &#8220;next-gen&#8221; clinical CRO with efficient operations, IT services and expertise in cross-border global trials. The company has 600 employees. Recently, dMed acquired Target Health, a full service New York-based CRO, to expand its global offerings and add new technologies.\u00a0<\/p>\n","protected":false},"author":9,"featured_media":298559,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-298576","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/298576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=298576"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/298576\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/298559"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=298576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=298576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=298576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}